Advisory Committee on Organ Transplantation Request for Nominations for Voting Members, 14058-14059 [2014-05375]
Download as PDF
<![CDATA[
14058
Federal Register / Vol. 79, No. 48 / Wednesday, March 12, 2014 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
Later Implementation Site Visit Interview Guide .................
List of Site HIV Outpatient Ambulatory Medical Care Activities/Services .................................................................
90
1
1
1
90
30
1
1
30/60
15
Total ..............................................................................
........................
........................
........................
........................
285
Dated: March 6, 2014.
Jackie Painter,
Deputy Director, Division of Policy and
Information Coordination.
[FR Doc. 2014–05376 Filed 3–11–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Committee on Organ
Transplantation Request for
Nominations for Voting Members
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
The Health Resources and
Services Administration (HRSA) is
requesting nominations to fill vacancies
on the Advisory Committee on Organ
Transplantation (ACOT). The ACOT
was established by the Amended Final
Rule of the Organ Procurement and
Transplantation Network (OPTN) (42
CFR Part 121) and, in accordance with
Public Law 92–463, was chartered on
September 1, 2000.
DATES: The agency will receive
nominations on a continuous basis.
ADDRESSES: All nominations should be
submitted to the Executive Secretary,
ACOT, Healthcare Systems Bureau,
HRSA, Parklawn Building, Room 12C–
06, 5600 Fishers Lane, Rockville,
Maryland 20857. Federal Express,
Airborne, UPS etc. mail delivery should
be addressed to Executive Secretary,
Advisory Committee on Organ
Transplantation, Healthcare Systems
Bureau, HRSA, at the above address, or
via email to: PStroup@hrsa.gov and
PTongele@hrsa.gov.
FOR FURTHER INFORMATION CONTACT:
Patricia A. Stroup, M.B.A., M.P.A.,
Executive Secretary, ACOT, at (301)
443–1127 or email pstroup@hrsa.gov.
SUPPLEMENTARY INFORMATION: As
provided by 42 CFR 121.12, the
Secretary established the ACOT. The
ACOT is governed by the Federal
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:51 Mar 11, 2014
Jkt 232001
Advisory Committee Act (5 U.S.C.
Appendix 2), which sets forth standards
for the formation and use of advisory
committees.
The ACOT advises the Secretary on
all aspects of organ procurement,
allocation, and transplantation, and on
other such matters that the Secretary
determines. One of its principal
functions is to advise the Secretary on
federal efforts to maximize the number
of deceased donor organs made
available for transplantation and to
support the safety of living organ
donation.
The ACOT consists of up to 25
members who are Special Government
Employees, and 5 ex-officio, non-voting
members. Members and the Chair shall
be appointed by the Secretary from
individuals knowledgeable in such
fields as deceased and living organ
donation, health care public policy,
transplantation medicine and surgery,
critical care medicine and other medical
specialties involved in the identification
and referral of donors, non-physician
transplant professions, nursing,
epidemiology, immunology, law and
bioethics, behavioral sciences,
economics and statistics, as well as
representatives of transplant candidates,
transplant recipients, living organ
donors, and family members of
deceased and living organ donors.
Members shall not serve while they are
also serving on the OPTN Board of
Directors. To the extent practicable,
Committee members should represent
minority, gender, and geographic
diversity of transplant candidates,
transplant recipients, organ donors, and
family members served by the OPTN.
The ex-officio, non-voting members
shall include the Directors of the
National Institutes of Health, the
Centers for Disease Control and
Prevention, and the Agency for
Healthcare Research and Quality; the
Administrator of the Centers for
Medicare and Medicaid Services; and
the Commissioner of the Food and Drug
Administration—or their designees.
Specifically, HRSA is requesting
nominations for voting members of the
ACOT representing: Health care public
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
policy; transplantation medicine and
surgery, including pediatric and heart/
lung transplantation; critical care
medicine; nursing; epidemiology and
applied statistics; immunology; law and
bioethics; behavioral sciences;
economics and econometrics; organ
procurement organizations; transplant
candidates/recipients; transplant/donor
family members; and living donors.
Nominees will be invited to serve up to
a 4-year term beginning the date of
appointment.
The Department of Health and Human
Services (HHS) will consider
nominations of all qualified individuals
with a view to ensuring that the ACOT
includes the areas of subject matter
expertise noted above. Individuals may
nominate themselves or other
individuals, and professional
associations and organizations may
nominate one or more qualified persons
for membership on the ACOT.
Nominations shall state that the
nominee is willing to serve as a member
of the ACOT and appears to have no
conflict of interest that would preclude
the ACOT membership. Potential
candidates will be asked to provide
detailed information concerning
financial interests, consultancies,
research grants, and/or contracts that
might be affected by recommendations
of the ACOT to permit evaluation of
possible sources of conflicts of interest.
A nomination package should include
the following information for each
nominee: (1) A letter of nomination
stating the name, affiliation, and contact
information for the nominee, the basis
for the nomination (i.e., what specific
attributes, perspectives, and/or skills
does the individual possess that would
benefit the workings of ACOT), and the
nominee’s field(s) of expertise; (2) a
biographical sketch of the nominee and
a copy of his/her curriculum vitae; and
(3) the name, address, daytime
telephone number, and email address at
which the nominator can be contacted.
HHS strives to ensure that the
membership of HHS Federal advisory
committees is fairly balanced in terms of
points of view represented and the
committee’s function. Every effort is
E:\FR\FM\12MRN1.SGM
12MRN1
Federal Register / Vol. 79, No. 48 / Wednesday, March 12, 2014 / Notices
made to ensure that the views of
women, all ethnic and racial groups,
and people with disabilities are
represented on HHS Federal advisory
committees. The Department also
encourages geographic diversity in the
composition of the committee. The
Department encourages nominations of
qualified candidates from all groups and
locations. Appointment to the ACOT
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, disability,
and cultural, religious, or
socioeconomic status.
Dated: March 6, 2014.
Jackie Pianter,
Deputy Director, Division of Policy and
Information Coordination.
[FR Doc. 2014–05375 Filed 3–11–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI—Clinical Trial
Cooperative Agreement Applications and
Other Clinically-Based Applications.
Date: April 10, 2014.
Time: 8:30 a.m. To 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Rockville, MD 20814.
Contact Person: Anne E. Schaffner, Ph.D.,
Chief, Scientific Review Branch, Division of
Extramural Research, National Eye Institute,
5635 Fishers Lane, Suite 1300, MSC 9300,
Bethesda, MD 20892–9300, (301) 451–2020,
aes@nei.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS).
VerDate Mar<15>2010
17:51 Mar 11, 2014
Jkt 232001
Dated: March 6, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05346 Filed 3–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
General Medical Sciences Special
Emphasis Panel, March 26, 2014, 1:00
p.m. to March 26, 2014, 4:00 p.m.,
National Institutes of Health, Natcher
Building, 45 Center Drive, Room
3An.18A, Bethesda, MD 20892 which
was published in the Federal Register
on March 5, 2014, 79 FR 12516.
The meeting will start on March 26,
2014 at 11:30 a.m. and end March 26,
2014 at 4:30 p.m. The meeting location
remains the same. The meeting is closed
to the public.
Dated: March 6, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05344 Filed 3–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Clinical Trials in Organ
Transplantation (U01).
Date: April 3–4, 2014.
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
14059
Time: April 3, 2014, 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, The
Madison Room, 1750 Rockville Pike,
Rockville, MD 20852.
Time: April 4, 2014, 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, The
Madison Room, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Andrea L Wurster, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, Room
3259, 6700B Rockledge Drive, MSC–7616,
Bethesda, MD 20892–761‘, 301–451–2660,
wurstera@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: March 6, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05267 Filed 3–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Health and
Aging.
Date: April 8, 2014.
Time: 2:00 p.m. to 3:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892.
Contact Person: Rebecca J. Ferrell, Ph.D.,
Scientific Review Officer, National Institute
on Aging, Gateway Building Rm. 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892,
301–402–7703, ferrellrj@mail.nih.gov.
E:\FR\FM\12MRN1.SGM
12MRN1
]]>Agencies
[Federal Register Volume 79, Number 48 (Wednesday, March 12, 2014)]
[Notices]
[Pages 14058-14059]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05375]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Committee on Organ Transplantation Request for
Nominations for Voting Members
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Health Resources and Services Administration (HRSA) is
requesting nominations to fill vacancies on the Advisory Committee on
Organ Transplantation (ACOT). The ACOT was established by the Amended
Final Rule of the Organ Procurement and Transplantation Network (OPTN)
(42 CFR Part 121) and, in accordance with Public Law 92-463, was
chartered on September 1, 2000.
DATES: The agency will receive nominations on a continuous basis.
ADDRESSES: All nominations should be submitted to the Executive
Secretary, ACOT, Healthcare Systems Bureau, HRSA, Parklawn Building,
Room 12C-06, 5600 Fishers Lane, Rockville, Maryland 20857. Federal
Express, Airborne, UPS etc. mail delivery should be addressed to
Executive Secretary, Advisory Committee on Organ Transplantation,
Healthcare Systems Bureau, HRSA, at the above address, or via email to:
PStroup@hrsa.gov and PTongele@hrsa.gov.
FOR FURTHER INFORMATION CONTACT: Patricia A. Stroup, M.B.A., M.P.A.,
Executive Secretary, ACOT, at (301) 443-1127 or email pstroup@hrsa.gov.
SUPPLEMENTARY INFORMATION: As provided by 42 CFR 121.12, the Secretary
established the ACOT. The ACOT is governed by the Federal Advisory
Committee Act (5 U.S.C. Appendix 2), which sets forth standards for the
formation and use of advisory committees.
The ACOT advises the Secretary on all aspects of organ procurement,
allocation, and transplantation, and on other such matters that the
Secretary determines. One of its principal functions is to advise the
Secretary on federal efforts to maximize the number of deceased donor
organs made available for transplantation and to support the safety of
living organ donation.
The ACOT consists of up to 25 members who are Special Government
Employees, and 5 ex-officio, non-voting members. Members and the Chair
shall be appointed by the Secretary from individuals knowledgeable in
such fields as deceased and living organ donation, health care public
policy, transplantation medicine and surgery, critical care medicine
and other medical specialties involved in the identification and
referral of donors, non-physician transplant professions, nursing,
epidemiology, immunology, law and bioethics, behavioral sciences,
economics and statistics, as well as representatives of transplant
candidates, transplant recipients, living organ donors, and family
members of deceased and living organ donors. Members shall not serve
while they are also serving on the OPTN Board of Directors. To the
extent practicable, Committee members should represent minority,
gender, and geographic diversity of transplant candidates, transplant
recipients, organ donors, and family members served by the OPTN. The
ex-officio, non-voting members shall include the Directors of the
National Institutes of Health, the Centers for Disease Control and
Prevention, and the Agency for Healthcare Research and Quality; the
Administrator of the Centers for Medicare and Medicaid Services; and
the Commissioner of the Food and Drug Administration--or their
designees.
Specifically, HRSA is requesting nominations for voting members of
the ACOT representing: Health care public policy; transplantation
medicine and surgery, including pediatric and heart/lung
transplantation; critical care medicine; nursing; epidemiology and
applied statistics; immunology; law and bioethics; behavioral sciences;
economics and econometrics; organ procurement organizations; transplant
candidates/recipients; transplant/donor family members; and living
donors. Nominees will be invited to serve up to a 4-year term beginning
the date of appointment.
The Department of Health and Human Services (HHS) will consider
nominations of all qualified individuals with a view to ensuring that
the ACOT includes the areas of subject matter expertise noted above.
Individuals may nominate themselves or other individuals, and
professional associations and organizations may nominate one or more
qualified persons for membership on the ACOT. Nominations shall state
that the nominee is willing to serve as a member of the ACOT and
appears to have no conflict of interest that would preclude the ACOT
membership. Potential candidates will be asked to provide detailed
information concerning financial interests, consultancies, research
grants, and/or contracts that might be affected by recommendations of
the ACOT to permit evaluation of possible sources of conflicts of
interest.
A nomination package should include the following information for
each nominee: (1) A letter of nomination stating the name, affiliation,
and contact information for the nominee, the basis for the nomination
(i.e., what specific attributes, perspectives, and/or skills does the
individual possess that would benefit the workings of ACOT), and the
nominee's field(s) of expertise; (2) a biographical sketch of the
nominee and a copy of his/her curriculum vitae; and (3) the name,
address, daytime telephone number, and email address at which the
nominator can be contacted.
HHS strives to ensure that the membership of HHS Federal advisory
committees is fairly balanced in terms of points of view represented
and the committee's function. Every effort is
[[Page 14059]]
made to ensure that the views of women, all ethnic and racial groups,
and people with disabilities are represented on HHS Federal advisory
committees. The Department also encourages geographic diversity in the
composition of the committee. The Department encourages nominations of
qualified candidates from all groups and locations. Appointment to the
ACOT shall be made without discrimination on the basis of age, race,
ethnicity, gender, sexual orientation, disability, and cultural,
religious, or socioeconomic status.
Dated: March 6, 2014.
Jackie Pianter,
Deputy Director, Division of Policy and Information Coordination.
[FR Doc. 2014-05375 Filed 3-11-14; 8:45 am]
BILLING CODE 4165-15-P
